Nexell Reports $8.3-Million Net Loss in Quarter

Irvine biotechnology company Nexell Therapeutics Inc. reported a fourth-quarter net loss of $8.3 million, or 43 cents a share, compared with a net loss of $9.9 million, or 55 cents a share, a year ago. Revenue declined 23% to $4.3 million.

For the year, the company lost $34.5 million, or $1.84 a share, compared with a net loss of $40.1 million, or $2.24 a share, for 1999. Revenue rose 21% to $18.2 million.